Craft

Endologix

Revenue

$143.4 M

FY, 2019

Endologix Summary

Company Summary

Overview
Endologix is a medical device company that provides therapies for the treatment of vascular disease. It offers abdominal stent grafts and endovascular systems to treat abdominal aortic aneurysms (AAA).
Type
Subsidiary
Status
Active
Founded
1992
HQ
Irvine, CA, US | view all locations
Website
http://www.endologix.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Cindy Pinto

    Cindy Pinto, Chief Financial Officer

    • Beth Rothwell

      Beth Rothwell, Chief Operating Officer

    • Genevieve Balutowski Dunbar

      Genevieve Balutowski Dunbar, Vice President, Regulatory Affairs

    • Christopher Leach

      Christopher Leach, Vice President, Sales Americas

    Operating MetricsView all

    Trademark Applications (US)

    2

    Jan, 2024

    Trademarks (US)

    16

    Jan, 2024

    LocationsView all

    4 locations detected

    • Irvine, CA HQ

      United States

      2 Musick

    • Milpitas, CA

      United States

      1971 Milmont Dr

    • Santa Rosa, CA

      United States

      3910 Brickway Blvd

    • 's-Hertogenbosch, NB

      Netherlands

      Europalaan 30

    Endologix Financials

    Summary Financials

    Revenue (Q2, 2020)
    $24.8M
    Gross profit (Q2, 2020)
    $14.2M
    Net income (Q2, 2020)
    ($26.1M)
    Cash (Q2, 2020)
    $18.5M
    EBIT (Q2, 2020)
    ($17.3M)

    Footer menu